Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Talimogene Laherparepvec (T-VEC) & Melanoma (cutaneous), Talimogene laherparepvec (T-VEC) is a modified herpes simplex virus type 1 that can be administered intralesionally to patients with unresectable stage IIIB/C-IVM1a (American Joint Committee of Cancer; AJCC 7th Edition) melanoma (5)
Talimogene Laherparepvec (T-VEC) is approved by the FDA (2015) for the local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with recurrent Melanoma (cutaneous) after initial surgery (1, 2, 3, 4)
In the [EU](brain://QMGe2vnxWkWiArAahJp9aA/EuropeanMedicinesAgencyEmaApprovalsOrAuthor…